Ekso Bionics Holdings, Inc. (EKSO)
EKSO Stock Price Chart
Explore Ekso Bionics Holdings, Inc. interactive price chart. Choose custom timeframes to analyze EKSO price movements and trends.
EKSO Company Profile
Discover essential business fundamentals and corporate details for Ekso Bionics Holdings, Inc. (EKSO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
17 Jan 2014
Employees
61.00
Website
https://www.eksobionics.comCEO
Scott G. Davis
Description
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
EKSO Financial Timeline
Browse a chronological timeline of Ekso Bionics Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Oct 2025
EPS estimate is -$0.99, while revenue estimate is $4.16M.
Earnings released on 28 Jul 2025
EPS came in at -$1.24 falling short of the estimated -$1.20 by -3.33%, while revenue for the quarter reached $2.06M , missing expectations by -50.39%.
Stock split effective on 2 Jun 2025
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 27 May 2025
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 5 May 2025
EPS came in at -$1.80 falling short of the estimated -$1.65 by -9.09%, while revenue for the quarter reached $3.38M , missing expectations by -38.74%.
Earnings released on 3 Mar 2025
EPS came in at -$0.14 falling short of the estimated -$0.07 by -100.00%, while revenue for the quarter reached $5.09M , beating expectations by +6.04%.
Earnings released on 28 Oct 2024
EPS came in at -$0.10 falling short of the estimated -$0.08 by -25.00%, while revenue for the quarter reached $4.13M , missing expectations by -22.13%.
Earnings released on 29 Jul 2024
EPS came in at -$0.13 falling short of the estimated -$0.11 by -18.18%, while revenue for the quarter reached $4.95M , missing expectations by -4.26%.
Earnings released on 29 Apr 2024
EPS came in at -$0.20 falling short of the estimated -$0.16 by -25.00%, while revenue for the quarter reached $3.76M , missing expectations by -24.88%.
Earnings released on 4 Mar 2024
EPS came in at -$0.22 falling short of the estimated -$0.11 by -100.00%, while revenue for the quarter reached $4.85M , beating expectations by +1.61%.
Earnings released on 26 Oct 2023
EPS came in at -$0.24 surpassing the estimated -$0.31 by +22.58%, while revenue for the quarter reached $4.61M , beating expectations by +0.15%.
Earnings released on 27 Jul 2023
EPS came in at -$0.31 falling short of the estimated -$0.28 by -10.71%, while revenue for the quarter reached $4.70M , beating expectations by +4.51%.
Earnings released on 27 Apr 2023
EPS came in at -$0.33 falling short of the estimated -$0.31 by -6.45%, while revenue for the quarter reached $4.12M , beating expectations by +16.08%.
Earnings released on 28 Mar 2023
EPS came in at -$0.24 falling short of the estimated -$0.22 by -9.09%, while revenue for the quarter reached $3.55M , missing expectations by -9.87%.
Earnings released on 3 Nov 2022
EPS came in at -$0.33 falling short of the estimated -$0.24 by -37.50%, while revenue for the quarter reached $3.33M , missing expectations by -7.09%.
Earnings released on 28 Jul 2022
EPS came in at -$0.23 surpassing the estimated -$0.24 by +4.17%, while revenue for the quarter reached $3.47M , missing expectations by -0.83%.
Earnings released on 28 Apr 2022
EPS came in at -$0.36 surpassing the estimated -$0.41 by +12.20%, while revenue for the quarter reached $2.57M , missing expectations by -19.78%.
Earnings released on 24 Feb 2022
EPS came in at -$0.23 surpassing the estimated -$0.25 by +8.00%, while revenue for the quarter reached $4.08M , beating expectations by +47.57%.
Earnings released on 2 Nov 2021
EPS came in at -$0.17 surpassing the estimated -$0.25 by +32.00%, while revenue for the quarter reached $3.05M , beating expectations by +18.18%.
Earnings released on 29 Jul 2021
EPS came in at -$0.26 falling short of the estimated -$0.25 by -4.00%, while revenue for the quarter reached $2.21M , beating expectations by +5.29%.
Earnings released on 29 Apr 2021
EPS came in at -$0.34 falling short of the estimated -$0.24 by -41.67%, while revenue for the quarter reached $1.91M , beating expectations by +3.90%.
Earnings released on 25 Feb 2021
EPS came in at -$0.48 falling short of the estimated -$0.30 by -60.00%, while revenue for the quarter reached $2.25M , beating expectations by +1.01%.
Earnings released on 29 Oct 2020
EPS came in at -$0.52 falling short of the estimated -$0.40 by -30.00%, while revenue for the quarter reached $2.90M , missing expectations by -23.08%.
EKSO Stock Performance
Access detailed EKSO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.